INS and metabolic syndrome: They contribute to the occurrence of a cluster of disorders known as the metabolic syndrome—abdominal obesity, hypertension, dyslipidemia, and disturbed metabolism of glucose or insulin—which in turn accounts for a significant share of the global burden of disease [1].